FDA Adverse Event Injury Summary report: N

ONYX

MDR report key: 6501370 · Received April 18, 2017

Report

Report Number
2029214-2017-00460
Event Type
Injury
Date Received
April 18, 2017
Date of Event
October 1, 2016
Report Date
March 23, 2017
Manufacturer
MEDTRONIC COVIDIEN
Product Code
MFE
PMA / PMN Number
P030004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WILL NOT BE RETURNED FOR EVALUATION AS IT WAS IMPLANTED IN THE PATIENT. BASED ON THE REPORTED INFORMATION, THERE DID NOT APPEAR TO HAVE BEEN ANY DEFECT OF THE DEVICE DURING USE. THE EVENT OCCURRED IN THE PATIENT POST PROCEDURE AND ITS CAUSE WAS UNKNOWN. CITATION: D. LE FOLL, H. RAOULTA. J.C. FERRÉA, ET AL. ¿THE LEARNING CURVE EFFECT ON EMBOLIZATION OF CEREBRAL DURAL ARTERIOVENOUS FISTULA SINGLE-CENTER EXPERIENCE IN 48 CONSECUTIVE PATIENTS.¿ JOURNAL OF NEURORADIOLOGY 2017; 44, 52¿56. HTTP://DX.DOI.ORG/10.1016/J.NEURAD.2016. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THROUGH REVIEW OF LITERATURE THAT TWO PATIENTS, BOTH OF WHOM WERE TREATED WITH ONYX, THERE WAS DURAL ARTERIOVENOUS FISTULAS (DAVF) RECURRENCE OR WORSENING. FROM MAY 2008 TO OCTOBER 2014, 57 EMBOLIZATION PROCEDURES WERE ATTEMPTED ON 48 PATIENTS (37 MEN AND 11 WOMEN; MEDIAN AGE: 63.9 YEARS) FOR DAVF IN A SINGLE CENTER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
282123 ONYX AGENT, INJECTABLE, EMBOLIC MFE MEDTRONIC COVIDIEN

Patients

Seq Age Sex Outcome Treatment
1 64 YR Other